Over a billion people worldwide have livers with excess fat, which can lead to a host of medical problems. Researchers think AI tools can spot the condition—and help stop it—early enough to save lives.
The LinkedIn cofounder now has an AI drug discovery startup—and thinks not asking chatbots for medical advice is “bordering on committing malpractice.”
ARIA has a billion-dollar budget and big aspirations for tackling everything from epilepsy to Alzheimer's.
Evidence suggests reactivations of the varicella-zoster virus may accelerate aging and raise dementia risk. Now scientists want to know if vaccines and antivirals could help protect the brain.
As nights get hotter around the globe due to climate change, the prevalence of sleep apnea is expected to increase by as much as threefold.
New research has given credence to a 5,000-year-old practice.
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
Experts fear that Donald Trump’s anti-painkiller tirade could lead to an increase in risk factors for autism, and don’t trust the administration to assess data as it continues to search for a cause.
Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their viral loads to undetectable levels and then come off the medicine.
The WHO believes one in five children in Gaza are acutely malnourished, with the health effects potentially lasting for generations.
